Is tumor biopsy necessary?

Liver Transplantation

Volumn 17, Issue SUPPL. 2, 2011, Pages

  Müllhaupt, Beat ^a   Durand, Francois ^b   Roskams, Tanja ^c   Dutkowski, Philipp ^a   Heim, Markus ^d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b BEAUJON HOSPITAL   (France)

^c Department of Pathology ^*  (Belgium)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; END STAGE LIVER DISEASE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

ALGORITHMS; BIOPSY; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TISSUE DONORS; WAITING LISTS;

EID: 80053252810     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22374     Document Type: Article

References (59)

1. Bruix J, Sherman M,; for Practice Guidelines Committee of the American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236. (Pubitemid 43112690)
2. Bruix J, Sherman M,; for American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
3. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al.; for EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430. (Pubitemid 32844200)
4. Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl 2004; 10: 42-48. (Pubitemid 38885891)
5. Wiesner RH, Freeman RB, Mulligan DC,. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127 (suppl 1): S261-S267. (Pubitemid 39423395)
6. Compagnon P, Grandadam S, Lorho R, Turlin B, Camus C, Jianrong Y, et al. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy. Transplantation 2008; 86: 1068-1076.
7. Oxford Centre for Evidence-Based Medicine. Levels of evidence (March 2009). Accessed June 2011.
8. Deeks JJ, Altman DG,. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329: 168-169.
9. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS,. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA 2000; 284: 79-84. (Pubitemid 30445665)
10. Caturelli E, Bartolucci F, Biasini E, Vigliotti ML, Andriulli A, Siena DA, et al. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol 2002; 97: 397-405. (Pubitemid 34160767)
11. Caturelli E, Bisceglia M, Fusilli S, Squillante MM, Castelvetere M, Siena DA,. Cytological vs microhistological diagnosis of hepatocellular carcinoma: comparative accuracies in the same fine-needle biopsy specimen. Dig Dis Sci 1996; 41: 2326-2331.
12. Caturelli E, Solmi L, Anti M, Fusilli S, Roselli P, Andriulli A, et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 2004; 53: 1356-1362. (Pubitemid 39120127)
13. Durand F, Regimbeau JM, Belghiti J, Sauvanet A, Vilgrain V, Terris B, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001; 35: 254-258. (Pubitemid 32803481)
14. Bialecki ES, Ezenekwe AM, Brunt EM, Collins BT, Ponder TB, Bieneman BK, Di Bisceglie AM,. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006; 4: 361-368. (Pubitemid 43343894)
15. He YM, Wang XY, Gao SD, Yu LY, Lin XD, Lin LW,. Ultrasound-guided fine needle biopsy of intrahepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005; 4: 50-54.
16. Herszenyi L, Farinati F, Cecchetto A, Marafin C, de Maria N, Cardin R, Naccarato R,. Fine-needle biopsy in focal liver lesions: the usefulness of a screening programme and the role of cytology and microhistology. Ital J Gastroenterol 1995; 27: 473-478. (Pubitemid 26050951)
17. Huang GT, Sheu JC, Yang PM, Lee HS, Wang TH, Chen DS,. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinomaâa study based on 420 patients. J Hepatol 1996; 25: 334-338.
18. Wang P, Meng ZQ, Chen Z, Lin JH, Ping B, Wang LF, et al. Diagnostic value and complications of fine needle aspiration for primary liver cancer and its influence on the treatment outcomeâa study based on 3011 patients in China. Eur J Surg Oncol 2008; 34: 541-546. (Pubitemid 351514890)
19. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF,. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008; 57: 1592-1596.
20. Chapoutot C, Perney P, Fabre D, Taourel P, Bruel JM, Larrey D, et al. Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients [in French]. Gastroenterol Clin Biol 1999; 23: 552-556. (Pubitemid 29320956)
21. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ,. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000; 25: 246-250. (Pubitemid 30304979)
22. Kosugi C, Furuse J, Ishii H, Maru Y, Yoshino M, Kinoshita T, et al. Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: clinical and pathologic characteristics and the treatment of needle tract implantation. World J Surg 2004; 28: 29-32. (Pubitemid 38095788)
23. Maturen KE, Nghiem HV, Marrero JA, Hussain HK, Higgins EG, Fox GA, Francis IR,. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol 2006; 187: 1184-1187. (Pubitemid 44630819)
24. Takamori R, Wong LL, Dang C, Wong L,. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72. (Pubitemid 30123370)
25. Ch Yu S, Metreweli C, Lau WY, Leung WT, Liew CT, Leung NW,. Safety of percutaneous biopsy of hepatocellular carcinoma with an 18 gauge automated needle. Clin Radiol 1997; 52: 907-911.
26. Chang S, Kim SH, Lim HK, Lee WJ, Choi D, Lim JH,. Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma: evaluation of doubling time, frequency, and features on CT. AJR Am J Roentgenol 2005; 185: 400-405.
27. Ng KK, Poon RT, Lo CM, Liu CL, Lam CM, Ng IO, Fan ST,. Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center. Arch Surg 2004; 139: 193-200. (Pubitemid 38174716)
28. Wang CW, Lin ZY, Chuang WL, Wang LY, Yu ML, Chen SC, et al. Safety of fine-needle aspiration in patients with small hepatocellular carcinoma. Hepatol Res 2005; 31: 31-35.
29. Germani G, Pleguezuelo M, Stigliano R, Burroughs AK,. Risk of seeding is reduced by associating diagnostic biopsy with percutaneous ablation for hepatocellular carcinoma. Gut 2009; 58: 734-735.
30. Dumortier J, Lombard-Bohas C, Valette PJ, Boillot O, Scoazec JY, Berger F, Claudel-Bonvoisin S,. Needle tract recurrence of hepatocellular carcinoma after liver transplantation. Gut 2000; 47: 301. (Pubitemid 30489778)
31. Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, Duca P,. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006; 101: 513-523. (Pubitemid 43340927)
32. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al.; for Barcelona Clínic Liver Cancer Group. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003; 38: 1034-1042. (Pubitemid 37221687)
33. Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, Joh JW,. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000; 175: 693-698.
34. Bennett GL, Krinsky GA, Abitbol RJ, Kim SY, Theise ND, Teperman LW,. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 2002; 179: 75-80. (Pubitemid 34694814)
35. Chalasani N, Horlander JC Sr, Said A, Hoen H, Kopecky KK, Stockberger SM Jr, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999; 94: 2988-2993. (Pubitemid 29482770)
36. Dodd GD III, Miller WJ, Baron RL, Skolnick ML, Campbell WL,. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. AJR Am J Roentgenol 1992; 159: 727-733.
37. Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD,. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000; 95: 1535-1538. (Pubitemid 30396316)
38. Kim CK, Lim JH, Lee WJ,. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001; 20: 99-104.
39. Kobayashi K, Sugimoto T, Makino H, Kumagai M, Unoura M, Tanaka N, et al. Screening methods for early detection of hepatocellular carcinoma. Hepatology 1985; 5: 1100-1105. (Pubitemid 16222276)
40. Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002; 8: 749-761. (Pubitemid 35012282)
41. Maringhini A, Cottone M, Sciarrino E, Marcena MP, La Seta F, Rinaldi F, Pagliaro L,. Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels. Cancer 1984; 54: 2924-2926. (Pubitemid 15184072)
42. Okazaki N, Yoshida T, Yoshino M, Matue H,. Screening of patients with chronic liver disease for hepatocellular carcinoma by ultrasonography. Clin Oncol 1984; 10: 241-246. (Pubitemid 15091914)
43. Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001; 25: 327-336. (Pubitemid 32440782)
44. Saada J, Bhattacharya S, Dhillon AP, Dick R, Burroughs AK, Rolles K, Davidson BR,. Detection of small hepatocellular carcinomas in cirrhotic livers using iodised oil computed tomography. Gut 1997; 41: 404-407. (Pubitemid 27428204)
45. Tanaka S, Kitamura T, Ohshima A, Umeda K, Okuda S, Ohtani T, et al. Diagnostic accuracy of ultrasonography for hepatocellular carcinoma. Cancer 1986; 58: 344-347. (Pubitemid 16058613)
46. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 2003; 226: 533-542. (Pubitemid 36313446)
47. Tong MJ, Blatt LM, Kao VW,. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001; 16: 553-559. (Pubitemid 34188864)
48. de Lédinghen V, Laharie D, Lecesne R, Le Bail B, Winnock M, Bernard PH, et al. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 2002; 14: 159-165. (Pubitemid 34163995)
49. Mortelé KJ, De Keukeleire K, Praet M, Van Vlierberghe H, de Hemptinne B, Ros PR,. Malignant focal hepatic lesions complicating underlying liver disease: dual-phase contrast-enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients. Eur Radiol 2001; 11: 1631-1638. (Pubitemid 32821370)
50. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH III, Confer SR, Hunt LE,. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000; 217: 743-749.
51. Zacherl J, Pokieser P, Wrba F, Scheuba C, Prokesch R, Zacherl M, et al. Accuracy of multiphasic helical computed tomography and intraoperative sonography in patients undergoing orthotopic liver transplantation for hepatoma: what is the truth? Ann Surg 2002; 235: 528-532. (Pubitemid 34258352)
52. Bhartia B, Ward J, Guthrie JA, Robinson PJ,. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 2003; 180: 577-584. (Pubitemid 36237194)
53. Born M, Layer G, Kreft B, Schwarz N, Schild H,. MRI, CT and CT arterial portography in the diagnosis of malignant liver tumors in liver cirrhosis [in German]. Rofo 1998; 168: 567-572.
54. Krinsky GA, Lee VS, Theise ND, Weinreb JC, Rofsky NM, Diflo T, Teperman LW,. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001; 219: 445-454. (Pubitemid 32336360)
55. Mori K, Scheidler J, Helmberger T, Holzknecht N, Schauer R, Schirren CA, et al. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 2002; 179: 1045-1051.
56. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47: 97-104. (Pubitemid 351171046)
57. Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009; 192: 1675-1681.
58. Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, Bolondi L,. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 2010; 105: 599-609.
59. Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010; 59: 638-644.